Skip to Main Content

Paper Details

Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis.
Cancer Epidemiol Biomarkers Prev
2
2022
15SNPs, Colorectal Cancer, DACHS, Oxaliplatin, PHS, PHSs, Patients, SNP, SNPs, colon cancer, colorectal cancer, germline genetic variants, mCRC, metastatic colorectal cancer, oxaliplatin, patients, predictive SNPs, rCC
Author NameAffiliation
Federico CanzianGerman Cancer Research Center (DKFZ)
Qian ShiMayo Clinic
Steven R AlbertsMayo Clinic
Andrew T ChanBrigham and Women's Hospital
Andrew T ChanHarvard T.H. Chan School of Public Health
Andrew T ChanMassachusetts General Hospital
Ulrike PetersFred Hutchinson Cancer Research Center
Ulrike PetersSchool of Public Health, University of Washington
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf
  • 1 - 10

Datasets

Release 1.2